KWIK-STIK and LYFO DISK, quality control kit for culture media Catalog # 0805K and 0805L

FDA Device Recall #Z-2124-2025 — Class II — June 17, 2025

Recall Summary

Recall Number Z-2124-2025
Classification Class II — Moderate risk
Date Initiated June 17, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Microbiologics Inc
Location Saint Cloud, MN
Product Type Devices
Quantity 21 total

Product Description

KWIK-STIK and LYFO DISK, quality control kit for culture media Catalog # 0805K and 0805L

Reason for Recall

Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause the user's quality control to fail and delayed diagnosis for the patient.

Distribution Pattern

US distribution to states of: Utah and Ohio; and OUS (International) to countries of: Italy, Netherlands, Argentina, Korea, Jordan, Spain, and Bangladesh.

Lot / Code Information

Lot #: 805-234-4, 805-234-5 UDI: (0805K) 30845357019531, (0805L) 10845357019544

Other Recalls from Microbiologics Inc

Recall # Classification Product Date
Z-0986-2026 Class II LYFO DISK, Campylobacter jejuni subsp. jejuni d... Dec 2, 2025
Z-0984-2026 Class II KWIK-STIK 2-Pack, Campylobacter jejuni subsp. j... Dec 2, 2025
Z-0985-2026 Class II KWIK-STIK 6-Pack, Campylobacter jejuni subsp. j... Dec 2, 2025
Z-0876-2026 Class II KWIK-STIK, Quality control kit for culture medi... Nov 13, 2025
Z-2195-2025 Class II LYFO-DISK, M. Canis Derived from ATCC 36299, pa... Jun 27, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.